
- www.ions.bio
- Business segment: Services | Biomarker Discovery
- ions.bio
- Am Klopferspitz 19
- 82152 Planegg/Martinsried
- Germany
- info@ions.bio

ions.bio
from left to right:
Dr. Philipp Geyer, Gründer & CSO, Geschäftsführer
Dr. Sebastian Virreira Winter, Günder & CTO, Geschäftsführer
Dr. Sophia Viellechner, Gründerin & CBO
About ions.bio
ions.bio offers a comprehensive, all-in-one solution for biomarker discovery. We design proprietary biomarker studies, partner with clinical experts to collect samples, and convert these samples into extensive multi-omics datasets. These datasets are rigorously analyzed using our advanced bioinformatics and AI-driven pipeline. The outcome is a new generation of innovative biomarkers. We actively collaborate with biotech and pharma companies, providing end-to-end support and services throughout the entire biomarker discovery and validation process.
What is your motivation?
At ions.bio, we are fueled by the desire to revolutionize healthcare through our expertise in mass spectrometry, advanced data analysis, and well-characterized biosamples. Our goal is to make groundbreaking discoveries in clinical samples, enabling earlier disease detection and the discovery of novel therapeutic targets. By harnessing cutting-edge technology and collaborating across disciplines, our dynamic team is committed to bridging this gap. We aim to push the boundaries of biomarker discovery, advancing precision medicine and ultimately improving patient outcomes through innovative solutions that can detect diseases sooner and guide the development of new drugs.
“The Innovation and Start-up Center Biotechnology (IZB) is a vibrant hub for biotech innovation, providing state-of-the-art facilities and fostering collaboration among over 40 companies. It serves as a critical platform for start-ups like ours, enabling us to tackle pressing medical challenges and drive advancements in biomarker discovery.”